marketcaparena
Search

    MDLN

    Medline Inc.

    Company overview

    Market capitalization
    $46.11B
    Employees
    45,000
    Latest publication
    2026-09-29
    About Medline Inc.

    Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-27 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue7,685,000,000USD7,787,000,000USD7,115,000,000USD6,886,000,000USD6,644,000,000USD6,388,000,000USD6,185,000,000USD
    Cost Of Revenue5,470,000,000USD5,873,000,000USD5,417,000,000USD5,157,000,000USD4,995,000,000USD4,804,000,000USD4,691,000,000USD
    Gross Profit2,215,000,000USD1,914,000,000USD1,698,000,000USD1,729,000,000USD1,649,000,000USD1,584,000,000USD1,494,000,000USD
    Selling General Administrative1,295,000,000USD1,265,000,000USD——1,070,000,000USD——
    Total Operating Expenses1,820,000,000USD1,489,000,000USD1,124,000,000USD1,100,000,000USD1,058,000,000USD1,010,000,000USD978,000,000USD
    Operating Income395,000,000USD425,000,000USD574,000,000USD629,000,000USD591,000,000USD574,000,000USD516,000,000USD
    Total Other Income Expense Net-160,000,000USD-219,000,000USD-229,000,000USD-270,000,000USD-253,000,000USD-236,000,000USD-216,000,000USD
    Interest Income49,000,000USD———34,000,000USD——
    Interest Expense168,000,000USD166,000,000USD228,000,000USD233,000,000USD214,000,000USD174,000,000USD267,000,000USD
    Income Before Tax235,000,000USD206,000,000USD345,000,000USD359,000,000USD338,000,000USD338,000,000USD300,000,000USD
    Income Tax Expense96,000,000USD26,000,000USD23,000,000USD26,000,000USD16,000,000USD14,000,000USD8,000,000USD
    Net Income139,000,000USD180,000,000USD322,000,000USD333,000,000USD322,000,000USD324,000,000USD292,000,000USD
    Minority Interest79,000,000USD———0USD——
    Net Income Applicable To Common Shares59,000,000USD——————
    Unclassified Operating Expenses—224,000,000USD1,124,000,000USD1,100,000,000USD-12,000,000USD1,010,000,000USD978,000,000USD
    Net Interest Income—-166,000,000USD——-210,000,000USD——
    Tax Provision—26,000,000USD——16,000,000USD——
    Net Income From Continuing Ops—180,000,000USD——322,000,000USD——
    Ebit—206,000,000USD573,000,000USD592,000,000USD552,000,000USD512,000,000USD567,000,000USD
    Ebitda—382,000,000USD826,000,000USD842,000,000USD799,000,000USD760,000,000USD806,000,000USD
    Depreciation And Amortization—176,000,000USD253,000,000USD250,000,000USD247,000,000USD248,000,000USD239,000,000USD
    Reconciled Depreciation—261,000,000USD—250,000,000USD247,000,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Revenue28,432,000,000USD25,507,000,000USD23,231,000,000USD21,448,000,000USD
    Cost Of Revenue20,914,000,000USD19,216,000,000USD18,008,000,000USD16,891,000,000USD
    Gross Profit7,518,000,000USD6,291,000,000USD5,223,000,000USD4,557,000,000USD
    Selling General Administrative4,524,000,000USD———
    Unclassified Operating Expenses782,000,000USD3,999,000,000USD3,719,000,000USD3,629,000,000USD
    Total Operating Expenses5,306,000,000USD4,066,000,000USD3,779,000,000USD3,687,000,000USD
    Operating Income2,212,000,000USD2,225,000,000USD1,444,000,000USD870,000,000USD
    Interest Expense812,000,000USD1,309,000,000USD1,375,000,000USD911,000,000USD
    Net Interest Income-812,000,000USD———
    Income Before Tax1,248,000,000USD1,246,000,000USD264,000,000USD10,000,000USD
    Income Tax Expense91,000,000USD46,000,000USD30,000,000USD35,000,000USD
    Tax Provision91,000,000USD———
    Net Income1,159,000,000USD1,200,000,000USD234,000,000USD-25,000,000USD
    Net Income From Continuing Ops1,157,000,000USD———
    Ebit1,248,000,000USD2,555,000,000USD1,639,000,000USD921,000,000USD
    Ebitda1,952,000,000USD3,532,000,000USD2,590,000,000USD1,854,000,000USD
    Depreciation And Amortization704,000,000USD977,000,000USD951,000,000USD933,000,000USD
    Reconciled Depreciation1,011,000,000USD———
    Total Other Income Expense Net-964,000,000USD-979,000,000USD-1,180,000,000USD-860,000,000USD
    Minority Interest2,000,000USD———
    Research Development—67,000,000USD60,000,000USD58,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-27 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets39,350,000,000USD39,014,000,000USD38,484,000,000USD36,883,000,000USD36,428,000,000USD———
    Cash And Equivalents2,327,000,000USD———————
    Cash And Short Term Investments2,677,000,000USD2,236,000,000USD1,939,000,000USD955,000,000USD584,000,000USD278,000,000USD——
    Short Term Investments350,000,000USD———————
    Total Current Assets11,742,000,000USD11,180,000,000USD10,679,000,000USD9,558,000,000USD8,947,000,000USD———
    Other Current Assets739,000,000USD463,000,000USD438,000,000USD426,000,000USD361,000,000USD-278,000,000USD——
    Other Non Current Assets22,911,000,000USD———————
    Total Liabilities20,273,000,000USD———————
    Total Current Liabilities2,710,000,000USD2,536,000,000USD2,490,000,000USD2,612,000,000USD2,351,000,000USD———
    Other Current Liabilities1,638,000,000USD———————
    Other Non Current Liabilities623,000,000USD———————
    Total Stockholder Equity11,572,000,000USD11,272,000,000USD10,737,000,000USD17,141,000,000USD16,951,000,000USD16,158,000,000USD16,524,000,000USD—
    Total Equity Including Noncontrolling Interest19,077,000,000USD———————
    Short Long Term Debt56,000,000USD77,000,000USD77,000,000USD—————
    Long Term Debt12,548,000,000USD12,495,000,000USD12,484,000,000USD—————
    Net Receivables3,661,000,000USD3,674,000,000USD3,533,000,000USD3,425,000,000USD3,340,000,000USD———
    Inventory4,665,000,000USD4,807,000,000USD4,769,000,000USD4,752,000,000USD4,662,000,000USD———
    Property Plant Equipment Net4,697,000,000USD4,758,000,000USD4,778,000,000USD4,690,000,000USD4,672,000,000USD———
    Goodwill8,072,000,000USD———————
    Intangible Assets13,538,000,000USD13,717,000,000USD13,893,000,000USD14,068,000,000USD14,246,000,000USD———
    Accounts Payable1,043,000,000USD932,000,000USD961,000,000USD990,000,000USD919,000,000USD———
    Short Term Debt29,000,000USD142,000,000USD77,000,000USD149,000,000USD145,000,000USD———
    Retained Earnings182,000,000USD122,000,000USD-7,000,000USD———0USD—
    Accumulated Other Comprehensive Income-6,000,000USD18,000,000USD27,000,000USD52,000,000USD62,000,000USD16,158,000,000USD——
    Total Liab—19,665,000,000USD19,198,000,000USD19,742,000,000USD19,477,000,000USD-16,158,000,000USD——
    Other Current Liab—1,462,000,000USD1,452,000,000USD1,473,000,000USD1,287,000,000USD———
    Capital Stock—0USD0USD———0USD—
    Good Will—8,076,000,000USD8,079,000,000USD8,069,000,000USD8,069,000,000USD———
    Cash—2,236,000,000USD1,939,000,000USD955,000,000USD584,000,000USD———
    Net Debt—10,401,000,000USD10,622,000,000USD15,695,000,000USD16,062,000,000USD———
    Short Long Term Debt Total—12,637,000,000USD12,561,000,000USD16,650,000,000USD16,646,000,000USD———
    Common Stock Shares Outstanding—825,000,000shares812,000,000shares787,118,025shares787,118,025shares799,799,804shares812,000,000shares787,118,025shares
    Non Current Assets Total—27,834,000,000USD27,805,000,000USD27,325,000,000USD27,481,000,000USD———
    Non Current Liabilities Total—17,129,000,000USD16,708,000,000USD17,130,000,000USD17,126,000,000USD-16,158,000,000USD——
    Non Current Liabilities Other—4,634,000,000USD4,224,000,000USD—————
    Non Currrent Assets Other—446,000,000USD1,055,000,000USD487,000,000USD475,000,000USD———
    Net Working Capital—8,644,000,000USD8,189,000,000USD—————
    Unclassified Non Current Assets—837,000,000USD——————
    Unclassified Current Liabilities—-77,000,000USD-77,000,000USD—————
    Unclassified Equity—11,132,000,000USD10,717,000,000USD367,000,000USD367,000,000USD—16,524,000,000USD—
    Common Stock———16,722,000,000USD16,522,000,000USD———
    Unclassified Non Current Liabilities———17,130,000,000USD17,126,000,000USD-16,158,000,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets38,484,000,000USD35,978,000,000USD36,122,000,000USD—
    Intangible Assets13,893,000,000USD14,559,000,000USD14,788,000,000USD—
    Other Current Assets438,000,000USD347,000,000USD451,000,000USD—
    Total Liab19,198,000,000USD19,454,000,000USD19,145,000,000USD—
    Total Stockholder Equity10,737,000,000USD16,524,000,000USD16,977,000,000USD—
    Other Current Liab1,452,000,000USD1,417,000,000USD1,313,000,000USD—
    Capital Stock0USD0USD——
    Retained Earnings-7,000,000USD0USD——
    Good Will8,079,000,000USD8,065,000,000USD7,532,000,000USD—
    Cash1,939,000,000USD250,000,000USD1,585,000,000USD—
    Cash And Short Term Investments1,939,000,000USD250,000,000USD1,585,000,000USD—
    Total Current Assets10,679,000,000USD8,272,000,000USD8,809,000,000USD—
    Total Current Liabilities2,490,000,000USD2,440,000,000USD2,131,000,000USD—
    Net Debt10,622,000,000USD16,649,000,000USD15,243,000,000USD—
    Short Term Debt77,000,000USD154,000,000USD122,000,000USD—
    Short Long Term Debt77,000,000USD———
    Short Long Term Debt Total12,561,000,000USD16,899,000,000USD16,828,000,000USD—
    Long Term Debt12,484,000,000USD———
    Net Receivables3,533,000,000USD3,219,000,000USD2,960,000,000USD—
    Inventory4,769,000,000USD4,456,000,000USD3,813,000,000USD—
    Accounts Payable961,000,000USD869,000,000USD696,000,000USD—
    Property Plant Equipment Net4,778,000,000USD4,979,000,000USD4,797,000,000USD—
    Accumulated Other Comprehensive Income27,000,000USD11,000,000USD188,000,000USD—
    Common Stock Shares Outstanding812,000,000shares787,118,025shares787,118,025shares787,118,025shares
    Non Current Assets Total27,805,000,000USD27,706,000,000USD27,313,000,000USD—
    Non Current Liabilities Total16,708,000,000USD17,014,000,000USD17,014,000,000USD—
    Non Current Liabilities Other4,224,000,000USD———
    Non Currrent Assets Other1,055,000,000USD55,000,000USD110,000,000USD—
    Net Working Capital8,189,000,000USD———
    Unclassified Current Liabilities-77,000,000USD———
    Unclassified Equity10,717,000,000USD366,000,000USD233,000,000USD—
    Common Stock—16,147,000,000USD16,556,000,000USD—
    Unclassified Non Current Liabilities—17,014,000,000USD17,014,000,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-27 · USD
    Depreciation510,000,000USD
    Stock Based Compensation52,000,000USD
    Deferred Income Tax101,000,000USD
    Other Non Cash Items-41,000,000USD
    Change To Account Receivables-148,000,000USD
    Change To Inventory-116,000,000USD
    Change To Liabilities237,000,000USD
    Change In Working Capital-515,000,000USD
    Operating Cash Flow1,127,000,000USD
    Capital Expenditures-207,000,000USD
    Other Investing Activities0USD
    Unclassified Investing Cash Flow-350,000,000USD
    Investing Cash Flow-557,000,000USD
    Common Stock Issuance1,000,000USD
    Net Common Stock Issuance-5,000,000USD
    Other Financing Activities-123,000,000USD
    Unclassified Financing Cash Flow-45,000,000USD
    Financing Cash Flow-172,000,000USD
    Effect Of Forex Changes On Cash-11,000,000USD
    Change In Cash387,000,000USD
    End Cash Flow2,329,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USD
    Net Income129,000,000USD180,000,000USD322,000,000USD333,000,000USD322,000,000USD324,000,000USD
    Depreciation254,000,000USD-91,000,000USD253,000,000USD250,000,000USD247,000,000USD248,000,000USD
    Stock Based Compensation23,000,000USD27,000,000USD—15,000,000USD19,000,000USD—
    Other Non Cash Items153,000,000USD422,000,000USD60,000,000USD163,000,000USD66,000,000USD88,000,000USD
    Change To Account Receivables-146,000,000USD-116,000,000USD-90,000,000USD-59,000,000USD-90,000,000USD-86,000,000USD
    Change To Inventory-42,000,000USD-15,000,000USD-89,000,000USD-71,000,000USD-89,000,000USD-250,000,000USD
    Change In Working Capital-161,000,000USD-282,000,000USD1,000,000USD-503,000,000USD1,000,000USD62,000,000USD
    Total Cash From Operating Activities412,000,000USD229,000,000USD636,000,000USD243,000,000USD636,000,000USD722,000,000USD
    Capital Expenditures-96,000,000USD342,000,000USD-101,000,000USD-140,000,000USD-101,000,000USD-107,000,000USD
    Free Cash Flow316,000,000USD571,000,000USD535,000,000USD103,000,000USD535,000,000USD615,000,000USD
    Total Cashflows From Investing Activities-96,000,000USD-138,000,000USD-101,000,000USD-134,000,000USD-101,000,000USD-998,000,000USD
    Net Borrowings0USD-4,049,000,000USD—-19,000,000USD0USD—
    Total Cash From Financing Activities-13,000,000USD897,000,000USD-161,000,000USD-176,000,000USD-161,000,000USD-558,000,000USD
    Sale Purchase Of Stock0USD-1,970,000,000USD-18,000,000USD3,000,000USD-18,000,000USD-3,000,000USD
    Change In Cash296,000,000USD-955,000,000USD371,000,000USD584,000,000USD-250,000,000USD—
    Begin Period Cash Flow1,942,000,000USD955,000,000USD584,000,000USD840,000,000USD250,000,000USD—
    End Period Cash Flow2,238,000,000USD1,942,000,000USD955,000,000USD584,000,000USD840,000,000USD584,000,000USD
    Other Cashflows From Financing Activities-10,000,000USD-96,000,000USD-119,000,000USD-184,000,000USD-119,000,000USD-42,000,000USD
    Unclassified Operating Cash Flow14,000,000USD-27,000,000USD—-15,000,000USD-19,000,000USD—
    Unclassified Financing Cash Flow-3,000,000USD7,108,000,000USD-24,000,000USD24,000,000USD-24,000,000USD-513,000,000USD
    Dividends Paid—-96,000,000USD————
    Other Cashflows From Investing Activities—-474,000,000USD—6,000,000USD—-1,000,000USD
    Unclassified Investing Cash Flow—-6,000,000USD———-890,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income1,159,000,000USD1,200,000,000USD234,000,000USD-25,000,000USD
    Depreciation1,011,000,000USD977,000,000USD951,000,000USD933,000,000USD
    Stock Based Compensation76,000,000USD———
    Other Non Cash Items357,000,000USD291,000,000USD325,000,000USD212,000,000USD
    Change To Account Receivables-355,000,000USD-256,000,000USD-153,000,000USD-376,000,000USD
    Change To Inventory-264,000,000USD-545,000,000USD444,000,000USD-195,000,000USD
    Change In Working Capital-783,000,000USD-675,000,000USD199,000,000USD-919,000,000USD
    Total Cash From Operating Activities1,744,000,000USD1,769,000,000USD1,685,000,000USD187,000,000USD
    Capital Expenditures-447,000,000USD-364,000,000USD-285,000,000USD-254,000,000USD
    Free Cash Flow1,297,000,000USD1,405,000,000USD1,400,000,000USD-67,000,000USD
    Total Cashflows From Investing Activities-474,000,000USD-1,493,000,000USD-312,000,000USD-264,000,000USD
    Net Borrowings-4,092,000,000USD———
    Total Cash From Financing Activities399,000,000USD-1,613,000,000USD-191,000,000USD-84,000,000USD
    Dividends Paid-518,000,000USD—-114,000,000USD—
    Sale Purchase Of Stock-2,003,000,000USD-20,000,000USD——
    Issuance Of Capital Stock7,048,000,000USD0USD0USD—
    Change In Cash1,689,000,000USD-1,335,000,000USD1,585,000,000USD—
    Begin Period Cash Flow250,000,000USD1,585,000,000USD——
    End Period Cash Flow1,939,000,000USD250,000,000USD1,585,000,000USD—
    Other Cashflows From Investing Activities-33,000,000USD-3,000,000USD——
    Other Cashflows From Financing Activities-36,000,000USD-1,518,000,000USD-114,000,000USD-23,000,000USD
    Unclassified Operating Cash Flow-76,000,000USD-24,000,000USD-24,000,000USD-14,000,000USD
    Unclassified Investing Cash Flow6,000,000USD-1,126,000,000USD-27,000,000USD-10,000,000USD
    Unclassified Financing Cash Flow7,048,000,000USD-75,000,000USD37,000,000USD-61,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-27GeographyInternational533,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27GeographyUnited States7,152,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27SegmentMedline Brand3,540,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-27SegmentSupply Chain Solutions4,145,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational495,000,000USD0002046386-26-000026
    Q1 2026Quarterly · 2026-03-31GeographyUnited States6,857,000,000USD0002046386-26-000026
    Q1 2026Quarterly · 2026-03-31SegmentMedline Brand3,465,000,000USD0002046386-26-000026
    Q1 2026Quarterly · 2026-03-31SegmentSupply Chain Solutions3,887,000,000USD0002046386-26-000026
    FY 2025Yearly · 2025-12-31GeographyInternational1,953,000,000USD0002046386-26-000009
    FY 2025Yearly · 2025-12-31GeographyUnited States26,479,000,000USD0002046386-26-000009
    FY 2025Yearly · 2025-12-31SegmentMedline Brand13,720,000,000USD0002046386-26-000009
    FY 2025Yearly · 2025-12-31SegmentSupply Chain Solutions14,712,000,000USD0002046386-26-000009
    Q1 2025Quarterly · 2025-03-31GeographyInternational450,000,000USD0002046386-26-000026
    Q1 2025Quarterly · 2025-03-31GeographyUnited States6,194,000,000USD0002046386-26-000026
    Q1 2025Quarterly · 2025-03-31SegmentMedline Brand3,264,000,000USD0002046386-26-000026
    Q1 2025Quarterly · 2025-03-31SegmentSupply Chain Solutions3,380,000,000USD0002046386-26-000026
    FY 2024Yearly · 2024-12-31GeographyInternational1,760,000,000USD0002046386-26-000009
    FY 2024Yearly · 2024-12-31GeographyUnited States23,747,000,000USD0002046386-26-000009
    FY 2024Yearly · 2024-12-31SegmentMedline Brand12,515,000,000USD0002046386-26-000009
    FY 2024Yearly · 2024-12-31SegmentSupply Chain Solutions12,992,000,000USD0002046386-26-000009
    FY 2023Yearly · 2023-12-31GeographyInternational1,431,000,000USD0002046386-26-000009
    FY 2023Yearly · 2023-12-31GeographyUnited States21,800,000,000USD0002046386-26-000009
    FY 2023Yearly · 2023-12-31SegmentMedline Brand11,613,000,000USD0002046386-26-000009
    FY 2023Yearly · 2023-12-31SegmentSupply Chain Solutions11,618,000,000USD0002046386-26-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.